{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:15:37Z","timestamp":1783570537944,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04678-9","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:16:22Z","timestamp":1777436182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of patients with hepatitis C virus\u2013related liver transplantation in a high-volume transplant center"],"prefix":"10.1186","volume":"26","author":[{"given":"Engin","family":"Ataman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Harputluoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u0131lmaz","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harika G\u00f6zde","family":"G\u00f6z\u00fckara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Alada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"\u0130nce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezai","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"4678_CR1","doi-asserted-by":"publisher","unstructured":"G\u00f6kahmeto\u011flu S, Polat C, Atalay MA, Sezgin GC, Erg\u00f6r G, Aygen. https:\/\/doi.org\/10.5152\/tjg.2022.21822PMCID: PMC9797710.","DOI":"10.5152\/tjg.2022.21822"},{"key":"4678_CR2","doi-asserted-by":"publisher","unstructured":"Akarca US, Unsal B, Sezgin O, Yalcin K, Akdogan M, Gonen C. https:\/\/doi.org\/10.5152\/tjg.2021.201171PMCID: PMC8975510.","DOI":"10.5152\/tjg.2021.201171"},{"key":"4678_CR3","doi-asserted-by":"publisher","unstructured":"Martinello M, Solomon SS, Terrault NA, Dore GJ, Hepatitis C. https:\/\/doi.org\/10.1016\/S0140-6736(23)01320-XPMID: 37741678.","DOI":"10.1016\/S0140-6736(23)01320-X"},{"key":"4678_CR4","doi-asserted-by":"crossref","unstructured":"Berenguer M. Liver transplant 2002;8:S14.","DOI":"10.1053\/jlts.2002.35781"},{"issue":"10","key":"4678_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1600-6143.2009.02702.x","volume":"87","author":"K Watt","year":"2009","unstructured":"Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Transplantation. 2009;87(10):1573\u201381. . Epub 2009 Jun 16. PMID: 19538491. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02702.x","journal-title":"Transplantation"},{"issue":"4","key":"4678_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/jlts.2003.50063","volume":"9","author":"A Zekry","year":"2003","unstructured":"Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury R et al. Impact of immunosuppression on hepatitis C recurrence after liver transplantation. J Liver Transpl Surg. 2003;9(4):339\u2013347. https:\/\/doi.org\/10.1053\/jlts.2003.50063. PMID: 12682883.","journal-title":"J Liver Transpl Surg"},{"issue":"4","key":"4678_CR7","first-page":"411","volume":"75","author":"E Bonaccorsi-Riani","year":"2012","unstructured":"Bonaccorsi-Riani E, Sempoux C, Piette N, Julliard O, Kabamba B, Goffin E, et al. Fibrosing cholestatic hepatitis in liver transplantation: clinical and histological features. Acta Gastroenterol Belg. 2012;75(4):411\u20138. PMID: 23402084.","journal-title":"Acta Gastroenterol Belg"},{"key":"4678_CR8","first-page":"227","volume":"22","author":"JM Kim","year":"2016","unstructured":"Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CH, Hwang S, et al. Outcome of hepatitis C virus infection after adult living donor liver transplantation: a single-center experience with interferon-based antiviral therapy. Clin Mol Hepatol. 2016;22:227\u201336. Epub 2015 Dec 29. PMID: 26793691; PMCID: PMC4717607.","journal-title":"Clin Mol Hepatol"},{"key":"4678_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","volume":"95","author":"AK Singal","year":"2013","unstructured":"Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755\u201360. [PubMed] [Google Scholar] [Ref list].","journal-title":"Transplantation"},{"key":"4678_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","volume":"57","author":"R Adam","year":"2012","unstructured":"Adam R, Karam V, Delvart V, O\u2019Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. J Hepatol. 2012;57:675\u201388. [PubMed] [Google Scholar] [Ref list].","journal-title":"J Hepatol"},{"issue":"2","key":"4678_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1526924820951034\/000510341","volume":"31","author":"N Lim","year":"2021","unstructured":"Lim N, Singh D, Jackson S, Lake JR. Recurrence of hepatocellular carcinoma after liver transplantation in the direct acting antiviral era. Prog Transpl. 2021;31(2):155\u201364. https:\/\/doi.org\/10.1177\/1526924820951034\/000510341. Epub 2020 Sep 14. PMID: 33173777; PMCID: PMC7590751.","journal-title":"Prog Transpl"},{"key":"4678_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.arcmed.2021.04.003","volume":"52","author":"E Kauffman-Ortega","year":"2021","unstructured":"Kauffman-Ortega E, Ruiz-Manriquez J, Olivas-Martinez A, Cordero-Perez P, et al. Direct-acting antivirals and outcome of liver transplantation for hepatitis C in the MELD era. Arch Med Res. 2021;52:453\u201360. Epub 2021 May 7. PMID: 33966917.","journal-title":"Arch Med Res"},{"key":"4678_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/tri.13424","volume":"32","author":"SS Arora","year":"2019","unstructured":"Arora SS, Axley P, Ahmed Z, Satapathy SK, Wong R, Kuo YF, et al. Hepatitis C virus infection, direct-acting antivirals, and post-liver transplant outcomes: a contemporary united States analysis. Transpl Int. 2019;32:854\u201364. https:\/\/doi.org\/10.1111\/tri.13424. Epub 2019 Mar 26. PMID: 30866110.","journal-title":"Transpl Int"},{"key":"4678_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2036.2010.04505.x","volume":"33","author":"P Guillouche","year":"2011","unstructured":"Guillouche P, Feray C. Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther. 2011;33:163\u201374. [PubMed] [Google Scholar] [Ref list].","journal-title":"Aliment Pharmacol Ther"},{"key":"4678_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/tri.12642","volume":"28","author":"P Burra","year":"2015","unstructured":"Burra P, De Martin E, Zanetto A, Senzolo M, Russo FP, et al. Hepatitis C virus infection in liver transplantation: who, when. how? Transpl Int. 2015;28:35\u201352. https:\/\/doi.org\/10.1111\/tri.12642. Epub 2015 Aug 11. PMID: 26199060.","journal-title":"how? Transpl Int"},{"key":"4678_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jhep.2011.06.031","volume":"56","author":"DN Samonakis","year":"2012","unstructured":"Samonakis DN, Germani G, Burroughs AK. Immunosuppression and recurrent viral hepatitis after liver transplantation. J Hepatol. 2012;56:973\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.031. Epub 2011 Sep 29. PMID: 21963518.","journal-title":"J Hepatol"},{"key":"4678_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/lt.20995","volume":"13","author":"NA Terrault","year":"2007","unstructured":"Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, et al. Outcomes in hepatitis C patients undergoing living versus deceased donor liver transplantation. Liver Transpl. 2007;13:122\u20139.","journal-title":"Liver Transpl"},{"key":"4678_CR18","doi-asserted-by":"publisher","unstructured":"\u00c7ekin AH, G\u00fcner R, \u00c7a\u011fkan \u0130nkaya A, O\u011fuz D, \u00d6zdemir O. Real-life experience with direct acting antiviral therapy for recurrent hepatitis C after liver transplantation in Turkey. Turk J Gastroenterol. 2023;34. . PMID: 37565793;PMCID: PMC10645295. https:\/\/doi.org\/10.5152\/tjg.2023.22749","DOI":"10.5152\/tjg.2023.22749"},{"key":"4678_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/liv.12616","volume":"35","author":"EC Verna","year":"2015","unstructured":"Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, et al. Low post-transplant survival in patients with hepatitis C virus\u2013associated fibrosing cholestatic hepatitis. Liver Int. 2015;35:510\u20137. [PubMed] [Google Scholar] [Ref list].","journal-title":"Liver Int"},{"issue":"S1","key":"4678_CR20","first-page":"660A","volume":"60","author":"MS Sulkowski","year":"2014","unstructured":"Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, et al. Safety and efficacy of sofosbuvir-containing regimens for hepatitis C in patients with decompensated cirrhosis or post\u2013liver transplantation: the HCV-TARGET study. Hepatology. 2014;60(S1):660A. [Google Scholar] [Ref list].","journal-title":"Hepatology"},{"key":"4678_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","volume":"371","author":"PY Kwo Jr","year":"2014","unstructured":"Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R Jr et al. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014;371:2375\u20132382. https:\/\/doi.org\/10.1056\/NEJMoa1408921. Epub 2014 Nov 11. PMID: 25386767.","journal-title":"N Engl J Med"},{"key":"4678_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jceh.2017.08.004","volume":"8","author":"NS Choudhary","year":"2018","unstructured":"Choudhary NS, Saigal S, Gautam D, Saraf N, Rastogi A, Goja S, Bhangui P, Soin AS. Efficacy and safety of Sofosbuvir-based regimens in treatment of recurrent hepatitis C virus infection after living donor liver transplantation. J Clin Exp Hepatol. 2018;8:3\u201310. Epub 2017 Sep 1. PMID: 29892173; PMCID: PMC5992320.","journal-title":"J Clin Exp Hepatol"},{"key":"4678_CR23","first-page":"740","volume":"32","author":"Y Qu","year":"2017","unstructured":"Qu Y, Guo Y, Li T. Efficacy and safety of sofosbuvir-based interferon-free therapies for hepatitis C in liver transplant recipients: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017;32:740\u20138. [PubMed] [Google Scholar] [Ref list].","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4678_CR24","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/liv.13652","volume":"38","author":"S Beinhardt","year":"2018","unstructured":"Beinhardt S, Al-Zoairy R, Kozbial K, St\u00e4ttermayer AF, Maieron A, Stauber R et al. Long-term outcomes of sofosbuvir-based therapy in liver transplant recipients with recurrent hepatitis C virus infection. Liver Int. 2018;38:1184\u20131197. https:\/\/doi.org\/10.1111\/liv.13652. Epub 2018 Jan 31. PMID: 29197145.","journal-title":"Liver Int"},{"issue":"2","key":"4678_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.15403\/jgld.2014.1121.272.100","volume":"27","author":"S Iacob","year":"2018","unstructured":"Iacob S, Cerban R, Pietrareanu C, Ester C, Iacob R, Gheorghe C, Popescu I, Gheorghe L. 100% sustained virological response in liver transplant recipients with recurrent hepatitis C virus infection treated with direct-acting antivirals. J Gastrointestin Liver Dis. 2018;27(2):139\u2013144. https:\/\/doi.org\/10.15403\/jgld.2014.1121.272.100. PMID: 29922758.","journal-title":"J Gastrointestin Liver Dis"},{"key":"4678_CR26","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa140892","volume":"371","author":"PY Kwo","year":"2014","unstructured":"Kwo PY, Mantry PS, Coaldey E, et al. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014;371:2375\u201382. https:\/\/doi.org\/10.1056\/NEJMoa140892.","journal-title":"N Engl J Med"},{"key":"4678_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/tri.13018","volume":"30","author":"P Carrai","year":"2017","unstructured":"Carrai P, Morelli C, Cordone G, et al. The Italian compassionate use of Sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes. Transpl Int. 2017;30:1253\u201365. https:\/\/doi.org\/10.1111\/tri.13018.","journal-title":"Transpl Int"},{"issue":"8","key":"4678_CR28","doi-asserted-by":"publisher","first-page":"e15050","DOI":"10.1111\/ctr.15050","volume":"37","author":"A Liu","year":"2023","unstructured":"Liu A, Angirekula M, Elhawary A, Mara K, Kulai T, Leise M, Watt KD. Progression of fibrosis in liver transplant recipients with recurrent hepatitis C treated with direct-acting antivirals. Clin Transpl. 2023;37(8):e15050. https:\/\/doi.org\/10.1111\/ctr.15050. Epub 2023 Jun 17. PMID: 37329298.","journal-title":"Clin Transpl"},{"issue":"32","key":"4678_CR29","doi-asserted-by":"publisher","first-page":"11069","DOI":"10.3748\/wjg.v20.i32.11069","volume":"20","author":"J Dumortier","year":"2014","unstructured":"Dumortier J, Boillot O, Scoazec JY. Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation. World J Gastroenterol. 2014;20(32):11069\u201381. https:\/\/doi.org\/10.3748\/wjg.v20.i32.11069. PMID: 25170196; PMCID: PMC4145750.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04678-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:43:03Z","timestamp":1783568583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04678-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4678"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04678-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7629220\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the principles expressed in the Declaration of Helsinki and approved by the Ethics Committee of Inonu University in line with the Declaration of Helsinki (19-03-2024**2024\/5697). Information an Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}